James Mancuso

Building better paths from scientific discovery to real-world impact.

At the intersection of research strategy, institutional development, and early commercialization, with a focus on immunology, cancer research, partnerships, and company formation.

Current emphasis
Helping shape systems that move scientific ideas toward licensing, partnerships, and selectively, new companies.
Long-term direction
Evolving from institutional strategy into translational building and venture creation around high-value scientific IP.

About

A research strategy and development leader working in immunology and cancer research. Interests include scientific planning, external partnerships, translational infrastructure, and the early stages of commercialization.

A growing focus is how institutions can do a better job of identifying promising intellectual property, de-risking it early, and creating clearer paths to licensing, partnership, or company formation.

The longer-term goal is helping build stronger systems that connect scientific discovery to durable external impact while returning meaningful value to the institutions and laboratories where that work begins.

Highlights

What I am building toward

The work that interests me most sits between institutional science and external execution: deciding what should be licensed, what should be developed further, and what should become a company.

Translational Strategy

Connecting strong scientific discovery to real-world impact through commercialization planning, licensing strategy, and company formation.

Partnership Building

Developing productive collaborations across academia, biotech, philanthropy, and emerging innovation ecosystems.

Research Leadership

Leading research planning, scientific communications, and institutional strategy in immunology and cancer research.

Focus areas

Especially interested in roles and collaborations that connect scientific leadership with translational strategy, value capture, and long-term platform building.

  • Immunology and cancer research
  • Research strategy and institutional development
  • Early commercialization and licensing pathways
  • Spinout and company formation planning
  • Partnerships across academic and industry settings

Writing

Thinking on scientific strategy, AI in research, translational infrastructure, and how discovery becomes impact.

All posts

Selective collaborations and conversations

Interested in thoughtful conversations around research strategy, translational development, licensing, early commercialization, and company-building around scientific IP.

Get in touch
All views expressed on this site are my own and do not represent the positions of MD Anderson Cancer Center or the James P. Allison Institute.